Evaluate the Safety and Immunogenicity of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by VABIOTECH (Vietnam) in Vietnamese Children Aged 9-24 Months
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2018
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Acronyms JECEVAX-3
- 14 Sep 2018 Status changed from recruiting to completed.
- 05 Jun 2018 Planned End Date changed from 30 Apr 2018 to 15 Jul 2018.
- 09 Oct 2017 Status changed from not yet recruiting to recruiting.